Genetic IL-6R variants and therapeutic inhibition of IL-6 receptor signalling in COVID-19 - Authors' reply

Subjects

Subjects :

2019-20 coronavirus outbreak
Signalling
Rheumatology
Coronavirus disease 2019 (COVID-19)
business.industry
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Immunology
Interleukin-6 receptor
Correspondence
Immunology and Allergy
Medicine
business
Virology

Details

ISSN :

26659913

Volume :

3

Issue :

2

Database :

OpenAIRE

Journal :

The Lancet. Rheumatology

Accession number :

edsair.doi.dedup.....6296ff9f789253bfc2ae7bb082c2854e